Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-134.73%
operating margin TTM
-145.17%
revenue TTM
22.99 Million
revenue per share TTM
0.31$
valuation ratios | |
|---|---|
| pe ratio | -13.50 |
| peg ratio | -0.34 |
| price to book ratio | 7.24 |
| price to sales ratio | 18.48 |
| enterprise value multiple | -13.12 |
| price fair value | 7.24 |
profitability ratios | |
|---|---|
| gross profit margin | 93.45% |
| operating profit margin | -145.17% |
| pretax profit margin | -134.73% |
| net profit margin | -134.73% |
| return on assets | -43.95% |
| return on equity | -46.62% |
| return on capital employed | -57.08% |
liquidity ratios | |
|---|---|
| current ratio | 3.81 |
| quick ratio | 3.70 |
| cash ratio | 0.70 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 297.00 |
| operating cycle | 385.09 |
| days of payables outstanding | 356.22 |
| cash conversion cycle | 28.87 |
| receivables turnover | 4.14 |
| payables turnover | 1.02 |
| inventory turnover | 1.23 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -22.19 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.43 |
| cash per share | 4.15 |
| operating cash flow per share | -2.37 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -22.19 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -39.45 |
Frequently Asked Questions
When was the last time SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) reported earnings?
SpringWorks Therapeutics, Inc. (SWTX) published its most recent earnings results on 09-05-2025.
What is SpringWorks Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)'s trailing twelve months ROE is -46.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. SpringWorks Therapeutics, Inc. (SWTX) currently has a ROA of -43.95%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SWTX's net profit margin stand at?
SWTX reported a profit margin of -134.73% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SWTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.81 in the most recent quarter. The quick ratio stood at 3.70, with a Debt/Eq ratio of 0.02.